Profile | GDS4284 / 242477_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 404.097 | 61 |
GSM687648 | Patient 402 control | 143.259 | 43 |
GSM687653 | Patient 403 control | 197.333 | 49 |
GSM687658 | Patient 404 control | 263.906 | 53 |
GSM687663 | Patient 411 control | 142.4 | 40 |
GSM687668 | Patient 422 control | 200.275 | 49 |
GSM687673 | Patient 424 control | 284.033 | 54 |
GSM687678 | Patient 425 control | 171.637 | 44 |
GSM687683 | Patient 427 control | 541.572 | 64 |
GSM687688 | Patient 428 control | 224.562 | 51 |
GSM687695 | Patient 441 control | 941.937 | 74 |
GSM687699 | Patient 443 control | 54.8413 | 22 |
GSM687704 | Patient 444 control | 114.718 | 37 |
GSM687707 | Patient 448 control | 162.044 | 40 |
GSM687712 | Patient 449 control | 204.806 | 48 |
GSM687719 | Patient 450 control | 322.049 | 54 |
GSM687724 | Patient 451 control | 242.393 | 50 |
GSM687728 | Patient 452 control | 418.912 | 61 |
GSM687646 | Patient 401 treated 24h | 451.098 | 61 |
GSM687649 | Patient 402 treated 24h | 141.003 | 43 |
GSM687665 | Patient 411 treated 24h | 123.56 | 36 |
GSM687651 | Patient 402 treated 4 weeks | 150.571 | 41 |
GSM687667 | Patient 411 treated 4 weeks | 152.019 | 42 |
GSM687670 | Patient 422 treated 24h | 261.127 | 52 |
GSM687671 | Patient 422 treated 4 weeks | 93.5672 | 34 |
GSM687654 | Patient 403 treated 24h | 196.416 | 50 |
GSM687675 | Patient 424 treated 24h | 453.767 | 61 |
GSM687685 | Patient 427 treated 24h | 535.159 | 64 |
GSM687656 | Patient 403 treated 4 weeks | 144.556 | 44 |
GSM687677 | Patient 424 treated 4 weeks | 398.457 | 60 |
GSM687687 | Patient 427 treated 4 weeks | 332.769 | 57 |
GSM687692 | Patient 428 treated 4h | 238.748 | 51 |
GSM687716 | Patient 449 treated 4h | 200.779 | 49 |
GSM687722 | Patient 450 treated 4h | 327.953 | 55 |
GSM687680 | Patient 425 treated 24h | 189.659 | 47 |
GSM687690 | Patient 428 treated 24h | 347.082 | 59 |
GSM687700 | Patient 443 treated 24h | 193.328 | 40 |
GSM687705 | Patient 444 treated 24h | 116.202 | 39 |
GSM687714 | Patient 449 treated 24h | 282.515 | 56 |
GSM687721 | Patient 450 treated 24h | 283.136 | 51 |
GSM687682 | Patient 425 treated 4 weeks | 333.404 | 58 |
GSM687694 | Patient 428 treated 4 weeks | 207.958 | 50 |
GSM687702 | Patient 443 treated 4 weeks | 141.056 | 39 |
GSM687718 | Patient 449 treated 4 weeks | 297.346 | 56 |
GSM687723 | Patient 450 treated 4 weeks | 248.811 | 51 |
GSM687661 | Patient 404 treated 4h | 242.624 | 51 |
GSM687710 | Patient 448 treated 4h | 209.905 | 49 |
GSM687726 | Patient 451 treated 4h | 135.117 | 37 |
GSM687730 | Patient 452 treated 4h | 392.417 | 48 |
GSM687660 | Patient 404 treated 24h | 334.908 | 56 |
GSM687697 | Patient 441 treated 24h | 487.868 | 61 |
GSM687709 | Patient 448 treated 24h | 263.185 | 52 |
GSM687725 | Patient 451 treated 24h | 26.8255 | 12 |
GSM687729 | Patient 452 treated 24h | 438.269 | 61 |
GSM687727 | Patient 451 treated 4 weeks | 86.0985 | 28 |
GSM687731 | Patient 452 treated 4 weeks | 355.234 | 57 |